Automated Flow Synthesis of Peptide–PNA Conjugates
Antisense peptide nucleic acids (PNAs) have yet to translate to the clinic because of poor cellular uptake, limited solubility, and rapid elimination. Cell-penetrating peptides (CPPs) covalently attached to PNAs may facilitate clinical development by improving uptake into cells. We report an efficie...
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
American Chemical Society (ACS)
2022
|
Online Access: | https://hdl.handle.net/1721.1/141205 |
_version_ | 1810987097018859520 |
---|---|
author | Li, Chengxi Callahan, Alex J Phadke, Kruttika S Bellaire, Bryan Farquhar, Charlotte E Zhang, Genwei Schissel, Carly K Mijalis, Alexander J Hartrampf, Nina Loas, Andrei Verhoeven, David E Pentelute, Bradley L |
author2 | Massachusetts Institute of Technology. Department of Chemistry |
author_facet | Massachusetts Institute of Technology. Department of Chemistry Li, Chengxi Callahan, Alex J Phadke, Kruttika S Bellaire, Bryan Farquhar, Charlotte E Zhang, Genwei Schissel, Carly K Mijalis, Alexander J Hartrampf, Nina Loas, Andrei Verhoeven, David E Pentelute, Bradley L |
author_sort | Li, Chengxi |
collection | MIT |
description | Antisense peptide nucleic acids (PNAs) have yet to translate to the clinic because of poor cellular uptake, limited solubility, and rapid elimination. Cell-penetrating peptides (CPPs) covalently attached to PNAs may facilitate clinical development by improving uptake into cells. We report an efficient technology that utilizes a fully automated fast-flow instrument to manufacture CPP-conjugated PNAs (PPNAs) in a single shot. The machine is rapid, with each amide bond being formed in 10 s. Anti-IVS2-654 PPNA synthesized with this instrument presented threefold activity compared to transfected PNA in a splice-correction assay. We demonstrated the utility of this approach by chemically synthesizing eight anti-SARS-CoV-2 PPNAs in 1 day. A PPNA targeting the 5' untranslated region of SARS-CoV-2 genomic RNA reduced the viral titer by over 95% in a live virus infection assay (IC50 = 0.8 μM). Our technology can deliver PPNA candidates to further investigate their potential as antiviral agents. |
first_indexed | 2024-09-23T11:44:41Z |
format | Article |
id | mit-1721.1/141205 |
institution | Massachusetts Institute of Technology |
language | English |
last_indexed | 2024-09-23T11:44:41Z |
publishDate | 2022 |
publisher | American Chemical Society (ACS) |
record_format | dspace |
spelling | mit-1721.1/1412052023-02-09T18:59:15Z Automated Flow Synthesis of Peptide–PNA Conjugates Li, Chengxi Callahan, Alex J Phadke, Kruttika S Bellaire, Bryan Farquhar, Charlotte E Zhang, Genwei Schissel, Carly K Mijalis, Alexander J Hartrampf, Nina Loas, Andrei Verhoeven, David E Pentelute, Bradley L Massachusetts Institute of Technology. Department of Chemistry Antisense peptide nucleic acids (PNAs) have yet to translate to the clinic because of poor cellular uptake, limited solubility, and rapid elimination. Cell-penetrating peptides (CPPs) covalently attached to PNAs may facilitate clinical development by improving uptake into cells. We report an efficient technology that utilizes a fully automated fast-flow instrument to manufacture CPP-conjugated PNAs (PPNAs) in a single shot. The machine is rapid, with each amide bond being formed in 10 s. Anti-IVS2-654 PPNA synthesized with this instrument presented threefold activity compared to transfected PNA in a splice-correction assay. We demonstrated the utility of this approach by chemically synthesizing eight anti-SARS-CoV-2 PPNAs in 1 day. A PPNA targeting the 5' untranslated region of SARS-CoV-2 genomic RNA reduced the viral titer by over 95% in a live virus infection assay (IC50 = 0.8 μM). Our technology can deliver PPNA candidates to further investigate their potential as antiviral agents. 2022-03-15T19:07:21Z 2022-03-15T19:07:21Z 2022-02-23 2022-03-15T19:04:32Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/141205 Li, Chengxi, Callahan, Alex J, Phadke, Kruttika S, Bellaire, Bryan, Farquhar, Charlotte E et al. 2022. "Automated Flow Synthesis of Peptide–PNA Conjugates." ACS Central Science, 8 (2). en 10.1021/acscentsci.1c01019 ACS Central Science Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf American Chemical Society (ACS) ACS |
spellingShingle | Li, Chengxi Callahan, Alex J Phadke, Kruttika S Bellaire, Bryan Farquhar, Charlotte E Zhang, Genwei Schissel, Carly K Mijalis, Alexander J Hartrampf, Nina Loas, Andrei Verhoeven, David E Pentelute, Bradley L Automated Flow Synthesis of Peptide–PNA Conjugates |
title | Automated Flow Synthesis of Peptide–PNA Conjugates |
title_full | Automated Flow Synthesis of Peptide–PNA Conjugates |
title_fullStr | Automated Flow Synthesis of Peptide–PNA Conjugates |
title_full_unstemmed | Automated Flow Synthesis of Peptide–PNA Conjugates |
title_short | Automated Flow Synthesis of Peptide–PNA Conjugates |
title_sort | automated flow synthesis of peptide pna conjugates |
url | https://hdl.handle.net/1721.1/141205 |
work_keys_str_mv | AT lichengxi automatedflowsynthesisofpeptidepnaconjugates AT callahanalexj automatedflowsynthesisofpeptidepnaconjugates AT phadkekruttikas automatedflowsynthesisofpeptidepnaconjugates AT bellairebryan automatedflowsynthesisofpeptidepnaconjugates AT farquharcharlottee automatedflowsynthesisofpeptidepnaconjugates AT zhanggenwei automatedflowsynthesisofpeptidepnaconjugates AT schisselcarlyk automatedflowsynthesisofpeptidepnaconjugates AT mijalisalexanderj automatedflowsynthesisofpeptidepnaconjugates AT hartrampfnina automatedflowsynthesisofpeptidepnaconjugates AT loasandrei automatedflowsynthesisofpeptidepnaconjugates AT verhoevendavide automatedflowsynthesisofpeptidepnaconjugates AT pentelutebradleyl automatedflowsynthesisofpeptidepnaconjugates |